Seattle, Wash.-based Atossa Genetics Inc. said it expects to raise $13.4 million via a rights offering that expired May 24.
The rights offering was priced at $1,000 per unit, and allowed eligible shareholders to receive a series B preferred stock and warrants to buy 284 common stock of the company at $4.05 each.
The series B stock is immediately convertible into 284 common shares of the company.
Atossa engaged Maxim Group LLC as dealer-manager in the offering.
